[Treatment of Parkinson's disease with bromocriptine].

No abstract is available for this paper.

• Publication year

  1976

• Venue

  La Nouvelle presse medicale

• Publication date

  1976-04-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/nejm197709012970914PMID 1037400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Reconstituting the complete biosynthesis of D-lysergic acid in yeast

  2022cites this paper
• 50 years since the discovery of bromocriptine

  2018cites this paper
• ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.

  2018cites this paper
• Seniors with Parkinson's Disease: Initial Medical Treatment

  2010cites this paper
• The scientific and clinical basis for the treatment of Parkinson disease (2009)

  2009cites this paper
• Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease

  2007cites this paper
• From molecular insights to new therapeutic avenues

  2006cites this paper
• Adjuvant treatment of parkinson's disease with dopamine agonists: Open trial with bromocriptine and CU 32-085

  2004cites this paper
• Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease

  2003cites this paper
• Treatment of Parkinson's Disease

  2003cites this paper
• Long-term studies of dopamine agonists

  2002cites this paper
• Switching from Bromocriptine to Ropinirole in Patients with Advanced Parkinson's Disease: Open Label Pilot Responses to Three Different Dose-Ratios

  2001cites this paper
• Dopamine Agonists

  2001cites this paper
• Treatment options for depression and psychosis in Parkinson's disease

  2001cites this paper
• Management of Parkinson's disease

  1998cites this paper
• An algorithm (decision tree) for the management of Parkinson’s disease (2001):

  1998cites this paper
• Induction of mania by apomorphine in a depressed Parkinsonian patient

  1992cites this paper
• Agonist substitution in advanced Parkinson's disease

  1989cites this paper
• D-1 and D-2 Agonists in Parkinson's Disease

  1987cites this paper
• Optimum Symptomatic Control of Parkinson's Disease with Dopaminergic Therapy

  1987cites this paper
• The safety of bromocriptine in long-term use: a review of the literature.

  1986cites this paper
• Effects of bromocriptine on Parkinsonism A nation‐wide collaborative double‐blind study

  1985cites this paper
• delta-Opioid Modulation of Striatal Dopaminergic Activity in Mice

  1985cites this paper
• Initial treatment of parkinsonism with 8‐alpha‐amino‐ergoline

  1985cites this paper
• Should Dopamine Agonists Be Given Early or Late? A Review of Nine Years Experience with Bromocriptine

  1984cites this paper
• Bromocriptine in Parkinson’s Disease: Results Obtained With High and Low Dose Therapy

  1984cites this paper
• Quantitative autoradiography of neurotransmitter receptors in Huntington disease

  1982cites this paper
• Pergolide‐induced circling in rats with 6‐hydroxydopamine lesions in the nigrostriatal pathway

  1982cites this paper
• Physiologic disposition of pergolide

  1981cites this paper
• Bromocriptine and Its Use in Parkinsonism

  1981cites this paper
• Erythromelalgia‐like eruption in parkinsonian patients treated with bromocriptine

  1981cites this paper
• Bromocriptine and domperidone in the treatment of Parkinson disease

  1981cites this paper
• Pergolide, a potent long‐acting dopamine‐receptor agonist

  1980cites this paper
• Bromocriptine and Parkinson's disease: A 16‐hour clinical evaluation

  1980cites this paper
• Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease

  1979cites this paper
• NEUROLEPTIC RECEPTORS: THEIR CHARACTERISTICS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM AND THEIR ALTERATION IN HUMAN NEUROPSYCHIATRIC DISORDERS

  1979cites this paper
• Long-term treatment of Parkinson's disease with bromocriptine.

  1979cites this paper
• Changing epidemiology of Parkinson's disease: Predicted effects of levodopa treatment

  1979cites this paper
• Bromocriptine in Parkinson disease

  1979cites this paper
• Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapy

  1979cites this paper
• Transfer of bromocriptine across the blood‐brain barrier in man

  1979cites this paper
• Lergotrile in Parkinson disease

  1979cites this paper
• The role of bromocriptine in the treatment of parkinsonism

  1979cites this paper
• Comparison between lergotrile and bromocriptine in parkinsonism

  1978cites this paper
• Bromocriptine in Lieu of Levodopa for Parkinson's Disease

  1978cites this paper
• Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa.

  1978cites this paper
• BROMOCRIPTINE VERSUS PLACEBO IN LEVODOPA TREATED PATIENTS WITH PARKINSON'S DISEASE

  1977cites this paper
• Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.

  1977cites this paper
• Experiences with a new ergoline (CF 25–397) in parkinsonism

  1977cites this paper